Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

Nature
V BarnabaF Balsano

Abstract

Specific B lymphocytes can act as very efficient antigen-presenting cells. They bind antigen with high affinity via their immunoglobulin receptors, process it through the class II major histocompatibility complex (MHC) pathway, and present its fragments to class II-restricted T lymphocytes. In general, exogenous antigens and noninfectious viral particles enter the class II pathway and are selectively associated with class II MHC molecules. The presentation of an exogenous antigen in association with class I molecules has been reported for only a few antigens, including the hepatitis B envelope antigen (HBenvAg). Here we demonstrate that antigen-specific B cells can efficiently deliver HBenvAg to the class I pathway, presenting its fragments to class I-restricted cytotoxic T lymphocytes (CTLs) which kill the specific B cells. This could represent a mechanism of suppression of neutralizing anti-hepatitis B virus (HBV) antibody response, a phenomenon that accompanies the development of the chronic HBV-carrier state.

References

Oct 1, 1987·Nature·U D StaerzA M Garner
May 9, 1985·Nature·A R NeurathC E Stevens
Apr 11, 1985·Nature·A Lanzavecchia
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D N StandringW J Rutter
Aug 1, 1983·The Journal of Experimental Medicine·R ShimonkevitzH Grey
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·H K Ziegler, E R Unanue

❮ Previous
Next ❯

Citations

Jan 1, 1997·Springer Seminars in Immunopathology·C M Walker
Jul 1, 1995·Research in Virology·M ParoliV Barnaba
Jun 16, 2000·Journal of Neuroimmunology·M ParoliV Barnaba
Jun 25, 2003·Journal of Hepatology·Antonio Bertoletti, Nikolai V Naoumov
Jan 8, 2004·Journal of Hepatology·Carlo FerrariSimona Urbani
Jan 6, 2000·Journal of Hepatology·S AbrignaniH H Hsu
Jan 23, 1998·Human Immunology·M G ChedidE J Yunis
Jun 1, 1996·Current Opinion in Immunology·A Lanzavecchia
Jul 10, 2013·Nature Medicine·T Jake Liang
Nov 21, 2007·Nature Medicine·Pisana Moroni RawsonVincenzo Barnaba
Oct 28, 1998·Scandinavian Journal of Immunology·C Keşmir, R J De Boer
Mar 21, 2002·Immunology and Cell Biology·A J FreemanA R Lloyd
Dec 16, 1993·The New England Journal of Medicine·J Collazos
May 1, 1992·The Journal of Experimental Medicine·A FrancoV Barnaba
Jun 1, 1996·The Journal of Experimental Medicine·F di Marzo VeroneseE Appella
Dec 8, 1998·The Journal of Experimental Medicine·S R BennettW R Heath
Sep 15, 2005·The Journal of Experimental Medicine·Daniele AccapezzatoVincenzo Barnaba
Nov 1, 1994·AIDS Research and Human Retroviruses·M R Hilleman
May 20, 1998·Viral Immunology·A P CaporossiV Barnaba
Oct 1, 1994·European Journal of Clinical Investigation·M C JungG R Pape
Apr 1, 1993·Allergy·V Barnaba
May 1, 1995·Tissue Antigens·T I MichalakW H Marshall
Jan 1, 1991·Journal of Gastroenterology and Hepatology·H Thomas
Jan 4, 1998·Journal of Gastroenterology and Hepatology·S L Tsai, S N Huang
Aug 1, 1996·Immunological Reviews·V Barnaba

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.